Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Titel:
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Auteur:
Sanz, Miguel A. Montesinos, Pau Vellenga, Edo Rayón, Consuelo de la Serna, Javier Parody, Ricardo Bergua, Juan M. León, Angel Negri, Silvia González, Marcos Rivas, Concha Esteve, Jordi Milone, Gustavo González, José D. Amutio, Elena Brunet, Salut García-Laraña, J. Colomer, Dolors Calasanz, María J. Chillón, Carmen Barragán, Eva Bolufer, Pascual Lowenberg, Bob